Marketgems Earnings Trader- Trading Strong or Weak Earnings Growth

[jenna]

AGEN interesting play here. http://www.thestreet.com/_yahoo/tech/marketmovers/10024608.html

Antigenics, Inc. develops high efficacy, low toxicity treatments for a wide range of cancers, infectious diseases and autoimmune and degenerative disorders. The Company's cancer portfolio includes Oncophage, a personalized cancer vaccine in Phase III trials and on the FDA's Fast Track development program, and two liposomal products in Phase II development: Aroplatin, a third generation platinum chemotherapeutic, and ATRA-IV, a form of vitamin A used to treat lymphoma. Other products in development include QS-21, an antibody adjuvant being tested in several advanced clinical vaccine programs in partnership with pharmaceutical companies, and AG-702, a genital herpes therapeutic in Phase I testing.